The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2009 by Kaplan Medical Center.
Recruitment status was Recruiting

Study NCT00868478 Information provided by Kaplan Medical Center

First Received on March 24, 2009. Last Updated on June 1, 2010 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Milatuzumab

Additional drug interventions recognized in this trial

Antibodies
Antibodies, Monoclonal

More general drug interventions related to this trial

Sponsors listed in this trial